Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts

Authors:

Abstract
Serious injection-related infections (SIRIs), including endocarditis, osteomyelitis, epidural abscess, septic arthritis, and bloodstream infections, have more than doubled in the past 2 decades, causing morbidity and mortality for people who inject drugs.1-3 Most SIRIs are associated with opioid use disorder (OUD), despite regional variation.4-6 One-year mortality rates are elevated after SIRIs, reaching nearly 30% for endocarditis.2,7-13 Typically, SIRIs are treated with 2 or more weeks of intravenous antibiotics in hospitals, at post–acute care facilities, or at home, costing the health system more than $700 million annually.14,15

This publication has 75 references indexed in Scilit: